# OnCo record nct06062810 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06062810/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06062810", "NCT06062810" ;
  schema:name "Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms"@en ;
  schema:alternateName "Drugs-SNPs"@en ;
  schema:description "A phase 2/3 trial of Raloxifene in advanced solid tumours, run by Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06062810/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06062810> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2025-06-21" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/raloxifene/> .